Nevertheless, the similar methylation levels between BC patients with different clinical characteristics further suggested that the aberrant methylation of S100P and HYAL2 could be applied for the detection of BC in general regardless of subtype and clinical status. The gene discussed is HYAL2; the disease is breast cancer.